期刊
AUTOIMMUNITY
卷 55, 期 2, 页码 127-135出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/08916934.2021.2023863
关键词
Diffuse large B-cell lymphoma; circ_0003645; miR-335-5p; NFIB
类别
资金
- Natural Science Foundation of Fujian Province [2020J011303, 2020J011299]
- Zhangzhou Natural Science Foundation Project [ZZ020J05]
This study revealed that circ_0003645 promotes the proliferation and glycolysis of DLBCL cells through the miR-335-5p/NFIB axis, providing a novel insight for DLBCL treatment.
Background Circular RNAs (circRNAs) are critical regulators for the development of many tumours, including diffuse large B-cell lymphoma (DLBCL). However, the role and mechanism of circ_0003645 in DLBCL progression remains obscure. Methods Quantitative real-time PCR was performed to measure the expression of circ_0003645, microRNA (miR)-335-5p and nuclear factor I/B (NFIB). Cell viability, apoptosis and cell cycle were measured by cell counting kit 8 assay and flow cytometry. Protein expression was assessed using western blot analysis, and cell glycolysis was evaluated by detecting glucose consumption and ATP/ADP ratios. Besides, dual-luciferase reporter assay and RIP assay were used to confirm RNA interaction. Results Our data showed that circ_0003645 expression was significantly upregulated in DLBCL tumour tissues. After circ_0003645 knockdown, the viability, cell cycle and glycolysis of DLBCL cells were inhibited, while cell apoptosis was promoted. MiR-335-5p could be sponged by circ_0003645, and NFIB was confirmed to be a downstream target of miR-335-5p. Function analysis revealed that anti-miR-335-5p reversed the regulation of si-circ_0003645 on DLBCL cell progression, and NFIB overexpression also abolished miR-335-5p-mediated the biological functions of DLBCL cells. Conclusion The present study revealed that circ_0003645 promoted the proliferation and glycolysis of DLBCL cells by the miR-335-5p/NFIB axis, which might provide a novel insight for DLBCL treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据